Stockreport

Japan approves AstraZeneca-Sanofi drug for prevention of RSV disease in infants [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi ( NASDAQ: SNY ), has been approved in Japan for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in infants. [Read more]